Latest Breaking News On - Medical oncology division - Page 1 : comparemela.com

Dr Shadman on the Comparative Efficacy of Currently Available BTK Inhibitors in CLL

Mazyar Shadman, MD, MPH, discusses results from a network meta-analysis on the comparative efficacy of BTK inhibitors in relapsed/refractory CLL.

Mazyar shadmanInnovators networkFred hutch cancer centerClinical research divisionOncology divisionUniversity of washington school medicineInnovators network endowed chairMedical oncology divisionWashington school

BTK Inhibitor Combinations Move to Forefront of CLL Investigations, Conversations

Mazyar Shadman, MD, MPH, details the efficacy of BTK inhibitors in the frontline treatment of CLL as well as safety considerations in the relapsed/refractory setting.

United statesNorth carolinaUniversity of washingtonAlan skarbnikMazyar shadmanAmerican society of hematology annual meeting expositionNovant health in charlotteInternational conference on malignant lymphomaOncology divisionUniversity of washington school medicineInnovators networkOnclive scientific interchangeWorkshop chronic lymphocytic leukemiaLatest dataClinical practiceInnovators network endowed chair

Pirtobrutinib, Liso-Cel Could Expand Treatment Arsenal for Relapsed/Refractory CLL

Mazyar Shadman, MD, MPH, discusses the evolution of BTK inhibitors in CLL, highlights how treatment patterns have evolved with the continued emergence of data on ibrutinib, acalabrutinib, and zanubrutinib, and expands on how pirtobrutinib and liso-cel could address unmet needs for this patient population.

Mazyar shadmanNational comprehensive cancer networkClinical research divisionOncology divisionHematologic malignancies at fred hutchinson cancer centerUniversity of washington school medicineMedical oncology divisionWashington schoolHematologic malignanciesFred hutchinson cancerB cell non hodgkin lymphomaChronic lymphocytic leukemiaCart cell therapyLiso cel

Strides in GI Cancer Subsets Influence Advances

Tanios S. Bekaii-Saab, MD, highlights the unmet needs in GI malignancies and discusses how interdisciplinary meetings, such as the 20th Annual Meeting of the International Society of Gastrointestinal Oncology, provide the framework for disseminating information and driving innovative advances.

United statesTanioss bekaii saabWeijing sunAmerican association of cancer research annual meetingOncology divisionUniversity of kansas school medicineMayo clinic college of medicinePhysician education resourceAnnual meetingInternational societyGastrointestinal oncologyMayo clinic collegeMayo clinicSprint professorMedical oncologyMedical oncology division

Geneseeq, Brazilian Hospital Partner on Co-establishment of In-house NGS Lab

Geneseeq, Brazilian Hospital Partner on Co-establishment of In-house NGS Lab
businessinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from businessinsider.com Daily Mail and Mail on Sunday newspapers.

Sao pauloRio pretoSanta catarinaSao jose do rio pretoXue wuDaniel araujoMauricio nogueiraGroup geneseeq technology incHospital deOncology division at hospital deGeneseeq technology incHospital de baseSao josGeneseeq canadaSao joseMedical director